Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › Theranos Settles Separate Cases With CMS, Arizona Attorney General

Theranos Settles Separate Cases With CMS, Arizona Attorney General

Apr 18, 2017
|
staff reporter

NEW YORK (360Dx) — Theranos said late Monday that it reached a deal with the Centers for Medicare & Medicaid Services to settle all outstanding legal and regulatory proceedings against the firm.

Separately, the firm today said it will reimburse Arizona residents $4.65 million for blood testing services that it performed between 2013 and 2016. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Regulatory News & FDA Approvals

  1. FDA Grants EUAs for SARS-CoV-2 Tests From Clinical Enterprise, Qorvo Biotechnologies

  2. Siemens Healthineers Gets CE Mark for Point-of-Care High-Sensitivity Cardiac Troponin I Test

  3. Snibe Diagnostic Obtains CE Mark for HIV Chemiluminescence Immunoassay

  4. Australian Firm AnteoTech Obtains CE Marking for COVID-19 Antigen Test, Reader

  5. PerkinElmer Preliminary Q1 Revenues Grow 98 Percent; FDA Issues EUA for PCR COVID-19 Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.